Mark E. Dmytruk - 11 Sep 2024 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
Chief Financial Officer
Signature
/s/ Karen Tepichin, Attorney-in-Fact
Issuer symbol
DNA
Transactions as of
11 Sep 2024
Net transactions value
-$7,085
Form type
4
Filing time
16 Sep 2024, 16:26:23 UTC
Previous filing
06 Aug 2024
Next filing
08 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNA Class A Common Stock Options Exercise +1,634 +6% 28,838 11 Sep 2024 Direct F1, F2
transaction DNA Class A Common Stock Options Exercise +453 +1.6% 29,291 11 Sep 2024 Direct F1, F2
transaction DNA Class A Common Stock Options Exercise +572 +2% 29,863 11 Sep 2024 Direct F1, F2
transaction DNA Class A Common Stock Options Exercise +34 +0.11% 29,897 11 Sep 2024 Direct F2, F3, F4
transaction DNA Class A Common Stock Sale $7,085 -1,148 -3.8% $6.17* 28,749 12 Sep 2024 Direct F2, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNA Restricted Stock Units Options Exercise -1,634 -15% 9,632 11 Sep 2024 Class A Common Stock 1,634 Direct F1, F2
transaction DNA Restricted Stock Units Options Exercise -453 -3.2% 13,594 11 Sep 2024 Class A Common Stock 453 Direct F1, F2, F6
transaction DNA Restricted Stock Units Options Exercise -572 -2.3% 24,064 11 Sep 2024 Class A Common Stock 572 Direct F1, F2, F7
transaction DNA Class B Common Stock Options Exercise -34 -0.22% 15,509 11 Sep 2024 Class A Common Stock 34 Direct F2, F3, F4, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2 This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024.
F3 Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock.
F4 Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date.
F5 Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
F6 The RSUs vest in 48 equal monthly installments, which began on April 1, 2023.
F7 The RSUs vest in 48 equal monthly installments, which began on April 1, 2024.
F8 Includes shares of Class B Common Stock that are subject to vesting conditions.

Remarks:

Chief Financial Officer